GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Lianhuan Pharmaceutical Co Ltd (SHSE:600513) » Definitions » Ending Cash Position

Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Ending Cash Position : ¥199 Mil (As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Jiangsu Lianhuan Pharmaceutical Co Ending Cash Position?

Jiangsu Lianhuan Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥199 Mil.

Jiangsu Lianhuan Pharmaceutical Co's quarterly Ending Cash Position increased from Sep. 2023 (¥176 Mil) to Dec. 2023 (¥250 Mil) but then declined from Dec. 2023 (¥250 Mil) to Mar. 2024 (¥199 Mil).

Jiangsu Lianhuan Pharmaceutical Co's annual Ending Cash Position declined from Dec. 2021 (¥323 Mil) to Dec. 2022 (¥309 Mil) and declined from Dec. 2022 (¥309 Mil) to Dec. 2023 (¥250 Mil).


Jiangsu Lianhuan Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Jiangsu Lianhuan Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Lianhuan Pharmaceutical Co Ending Cash Position Chart

Jiangsu Lianhuan Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 246.66 221.23 322.90 309.05 250.19

Jiangsu Lianhuan Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 236.22 188.55 175.83 250.19 198.64

Jiangsu Lianhuan Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Jiangsu Lianhuan Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=309.048+-58.858
=250

Jiangsu Lianhuan Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=250.19+-51.554
=199


Jiangsu Lianhuan Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Jiangsu Lianhuan Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Business Description

Traded in Other Exchanges
N/A
Address
No. 21 Wenfeng Road, Jiangsu Province, Yangzhou, Jiangsu, CHN, 225009
Jiangsu Lianhuan Pharmaceutical Co Ltd is engaged in producing benign prostatic hyperplasia, allergy and cardiovascular drugs.
Executives
Chu Qing Song senior management
Xia Chun Lai Director
Pan He Ping Directors, senior managers
Niu Ben senior management
Wu Wen Ge Director
Zhu Yong Jun senior management
Qian Zhen Hua Director
Shen Yi senior management
Huang Wen Tao senior management
Zhou Jun senior management
Tu Bin senior management
Qin Xiong Jian senior management

Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Headlines

No Headlines